Oligodendroglial tumors

Textbook of Neuro-Oncology

Volumn , Issue , 2005, Pages 167-176

  Kros, Johan M ^a   Zheng, Ping pin ^a   Wolbers, John G ^a   Bent, Martin J van den ^b  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845634092     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-8148-1.50026-7     Document Type: Chapter

References (23)

1. Bailey H, Bucy P Oligodendrogliomas of the brain. J Pathol 1929, 32:735-750.
2. Berger MS, Deliganis AV, Dobbins J, et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994, 74:1784-1791.
3. Burger PC What is an oligodendroglioma?. Brain Pathol 2002, 12:257-259.
4. Cairncross G, Macdonald D, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1994, 12:2013-2021.
5. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90:1473-1479.
6. Daumas-Duport C, Varlet P, Tucker ML, et al. Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 1997, 34:37-59.
7. De la Monte SM Uniform lineage of oligodendrogliomas. Am J Pathol 1989, 135:529-540.
8. Giannini C, Scheithauer BW, Weaver AL, et al. Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 2001, 60:248-262.
9. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002, 52:316-324.
10. Kros JM, Pieterman H, van Eden CG, et al. Oligodendroglioma: the Rotterdam-Dijkzigt experience. Neurosurgery 1994, 34:959-966. discussion 966,.
11. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001, 95:190-198.
12. Lu QR, Park JK, Noll E, et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. PNAS 1998, 11:10851-10856.
13. Mason WP, Krol GS, DeAngelis LM Low-grade oligodendroglioma responds to chemotherapy. Neurology 1996, 46:203-207.
14. Mueller W, Hartmann C, Hoffmann A, et al. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 2002, 161:313-319.
15. Olson JD, Riedel E, DeAngelis LM Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 2000, 54:1442-1448.
16. Puduvalli VK, Hashmi M, McAllister LD, et al. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 2003, 65:259-266.
17. Reifenberger J, Reifenberger G, Liu L, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994, 145:1175-1190.
18. Schiffer D, Dutto A, Cavalla P, et al. Role of apoptosis in the prognosis of oligodendrogliomas. Neurochem Int 1997, 31:245-250.
19. Smith MT, Ludwig CL, Godfrey AD, et al. Grading of oligodendrogliomas. Cancer 1983, 52:2107-2114.
20. Soffietti R, Ruda R, Bradac GB, et al. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery 1998, 43:1066-1073.
21. van den Bent MJ, Kros JM, Heimans JJ, et al. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group. Neurology 1998, 51:1140-1145.
22. van den Bent MJ, Looijenga LH, Langenberg K, et al. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer 2003, 97:1276-1284.
23. Yates AJ, Comas T, Scheithauer BW, et al. Glycolipid markers of astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol 1999, 58:1250-1262.